Xinhai Jiang

Statistics

Publications

Citations

192

H-Index

Active since

2018

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

University of Rochester

Xinhai Jiang is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in inflammatory signaling, inflammation, and life sciences.

ORCID

Publications per year

2018–2024

Publications

SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression

Tingting Feng, Peng Liu, Xiao Wang et al. · Atherosclerosis · 2018 · 34 citations

Life Sciences, Biochemistry, Molecular Biology +16

Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport

Jinque Luo, Xiao Wang, Xinhai Jiang et al. · The FASEB Journal · 2019 · 33 citations

Life Sciences, Immunology, Pharmacology +17

Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway

Xinhai Jiang, Weizhi Wang, Lijuan Lei et al. · International Journal of Biological Sciences · 2024 · 20 citations · Full text

Medicine, Pathobiology, Pharmacology +17

LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing

Ni Li, Yan Li, Xiaowan Han et al. · Frontiers in Pharmacology · 2022 · 19 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism

Xinhai Jiang, Yining Li, Weizhi Wang et al. · Frontiers in Pharmacology · 2020 · 17 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

1–5 of 10